Voice your opinion on congressional bill HR4866-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019

This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

HR6379-116, HR6800-116, HR14-116,

Senate Actions

IntroReferral
Sep. 22 2020	Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

House floor actions Actions

Floor
Sep. 21 2020	Motion to reconsider laid on the table Agreed to without objection. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4616-4617) DEBATE - The House proceeded with forty minutes of debate on H.R. 4866. Considered under suspension of the rules. (consideration: CR H4616-4618) Mrs. Dingell moved to suspend the rules and pass the bill, as amended.

Calendars
Sep. 17 2020	Placed on the Union Calendar, Calendar No. 413.

Committee
Sep. 17 2020	Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.

IntroReferral
Oct. 28 2019	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

Floor
Sep. 21 2020	Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

Committee
Sep. 17 2020	Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.

IntroReferral
Oct. 28 2019	Introduced in House Introduced in House

House committee actions Actions

Committee
Jul. 15 2020	Ordered to be Reported (Amended) by Voice Vote. Committee Consideration and Mark-up Session Held.
Mar. 11 2020	Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . Subcommittee Consideration and Mark-up Session Held.
Oct. 29 2019	Referred to the Subcommittee on Health.

House bill HR4866-116

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

House bill HR4866-116

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Promote the cause!

Or use this QR code